SCHEMBL537900

SCHEMBL537900

Clc1ccccc1C=Cc1nc2ccccc2s1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SNCA P37840 1/20 0.57
RAB9A P51151 7/20 0.54
MAPT P10636 7/20 0.54
MEN1 O00255 5/20 0.54
KMT2A Q03164 5/20 0.54
TDP1 Q9NUW8 1/20 0.54
ALDH1A1 P00352 5/20 0.53
NPC1 O15118 5/20 0.53
KDM4E B2RXH2 4/20 0.53
SMN1; SMN2 Q16637 2/20 0.51
APP P05067 1/20 0.51
INSR P06213 1/20 0.51
NCOA1 Q15788 1/20 0.51
ALOX5 P09917 1/20 0.48
EPHX2 P34913 1/20 0.48
CYP1A2 P05177 2/20 0.48
CYP2C19 P33261 2/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3447907 1.00 SNCA (0.57) SNCARAB9AMAPTMEN1KMT2A
SCHEMBL10619184 0.88 SNCA (0.65) SNCARAB9AMAPTMEN1KMT2A
SCHEMBL6496513 0.86 SNCA (0.57) SNCARAB9AMAPTMEN1KMT2A
SCHEMBL6496514 0.86 SNCA (0.57) SNCARAB9AMAPTMEN1KMT2A
SCHEMBL6115915 0.84 MAPT (0.54) SNCARAB9AMAPTMEN1KMT2A
SCHEMBL6115910 0.84 MAPT (0.54) SNCARAB9AMAPTMEN1KMT2A
SCHEMBL6116681 0.83 SNCA (0.53) SNCARAB9AMAPTMEN1KMT2A
SCHEMBL6116675 0.83 SNCA (0.53) SNCARAB9AMAPTMEN1KMT2A
SCHEMBL6117521 0.83 RAB9A (0.46) SNCARAB9AMAPTMEN1KMT2A
SCHEMBL6117515 0.83 RAB9A (0.46) SNCARAB9AMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2414355-A2 FLUORESCENT CELLULAR MARKERS Zayas, Beatriz (US) 2012-02-08 EP claimed
WO-2010135751-A2 FLUORESCENT CELLULAR MARKERS BEATRIZ ZAYAS BEATRIZ (US) 2010-11-25 WO claimed
US-20100256378-A1 FLUORESCENT CELLULAR MARKERS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-10-07 US claimed
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein BF RESEARCH INSTITUTE (JP) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein PRNP, PRPH, PCNP SNCA 20/4885RAB9A 1787/4885MAPT 7/4885
US-20100256378-A1 FLUORESCENT CELLULAR MARKERS AIFM1, CASP3, BAX SNCA 1855/4885RAB9A 862/4885MAPT 3510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.